Beating death is now a possibility, with Sam Altman, the CEO of OpenAI introducing his life-extension program – Retro Biosciences. Enjoy up to 10 years as healthy humans, as Altman's ground-breaking fusion power and biotechnology projects revolutionize the healthcare industry. With additional investments into Helion Energy, Longevity Vision Fund, Tempus, Elysium Health, and Valo Health, aged 37 Altman is a visionary!
. Celebrate the 40th anniversary of legendary artist manager Doc McGhee's McGhee Entertainment enterprise. IQ Magazine (Issue 118) introduces the minds behind Rome's Måneskin's sell-out Loud Kids Tour & the 10-year anniversary of women-led production company Ginger Owl. Read about ChatGPT,Austria's live entertainment & more - subscribe for £6.25/mo.
Uncovering treatments designed to help beat cancer - new study by NCCS uncovers how cancer cells trick the immune system and spread. Led by Prof. Gopal Iyer, researchers developed therapies to target pathways used by cancer to evade detection, ultimately paving way for more effective cancer treatments.
This research conducted by UC San Diego Moores Cancer Center & Ludwig Cancer Research UC San Diego has revealed a significant link between Epstein-Barr virus (EBV) and certain types of cancer. EBV is widely present across the globe, and this study has showed that it has the ability to cause chromosomal breaks and activate cancer-causing proteins. It is thus essential to spread awareness and practice good hygiene habits to reduce risk of cancer caused by EBV.
. Indian startup PredOmix develops an AI-based blood test for detecting cancer that has a 98% accuracy rate. With OncoVeryx-F technology and metabolomics, PredOmix detects 32 cancers in one test. Clinical trials with thousands of participants can detect cancer earlier, improving treatment outcomes and saving lives. PredOmix has a mission to improve medical care through the universal access of basic medical resources.
Explore the evolution of tech policy from Obama's optimism to Harris's vision at the Democratic National Convention. What's next for Democrats in tech?